Table 2.
Median Values of TO and TS Depending on Clinical Characteristics
| Clinical Covariates | Group | TO (%) | P | TS (ms/RR) | P | ||
|---|---|---|---|---|---|---|---|
| Age (years) | >60 | −1.07 | 0.11 | 7.08 | 0.12 | ||
| <60 | −1.50 | 8.60 | |||||
| Gender | F | −1.01 | 0.50 | 8.56 | 0.89 | ||
| M | −1.30 | 8.15 | |||||
| Prior MI | (+) | −0.99 | 0.007 | 8.13 | 0.54 | ||
| (−) | −1.60 | 8.53 | |||||
| EF < 40% | (+) | −0.36 | 0.04 | 2.32 | 0.04 | ||
| (−) | −1.31 | 8.54 | |||||
| Diabetes | (+) | −1.08 | 0.64 | 5.82 | 0.12 | ||
| (−) | −1.40 | 8.53 | |||||
| Hypertension | (+) | −1.16 | 0.42 | 8.15 | 0.69 | ||
| (−) | −1.27 | 8.24 | |||||
| Smoking | (+) | −1.29 | 0.62 | 7.82 | 0.97 | ||
| (−) | −1.16 | 8.07 | |||||
| BMI > 25 kg/m2 | (+) | −1.36 | 0.10 | 8.15 | 0.59 | ||
| (−) | −0.88 | 8.90 | |||||
| Beta‐blockers | (+) | −1.28 | 0.68 | 8.57 | 0.03 | ||
| (−) | −1.15 | 5.62 | |||||
| Calcium blockers | (+) | −1.07 | 0.99 | 5.23 | 0.30 | ||
| (−) | −1.27 | 8.33 | |||||
| ACE inhibitors | (+) | −1.11 | 0.95 | 7.56 | 0.49 | ||
| (−) | −1.38 | 8.40 | |||||
| Statins | (+) | −1.30 | 0.30 | 8.75 | 0.02 | ||
| (−) | −0.98 | 5.23 | |||||
| Nitrates | (+) | −1.28 | 0.30 | 8.53 | 0.06 | ||
| (−) | −0.72 | 4.50 |
Variables with significant (p < 0.05) differences in HRT parameters between respective subgroups are in bold.
Abbreviations as in text.